Form 4: Mereo BioPharma Executive Sells Shares to Cover Tax Obligations

Alexandra Hughes-Wilson, a Mereo BioPharma Group plc officer, sold American Depositary Shares (ADS) to cover tax withholding obligations related to vested restricted stock units.

Summary

• Alexandra Hughes-Wilson, Chief Patient Access and Commercial Planning at Mereo BioPharma Group plc, reported the sale of American Depositary Shares (ADS) on June 25 and June 26, 2024.
• The sales were executed to cover tax withholding obligations related to the vesting of performance-based restricted stock units under the company's 2019 Employee Incentive Plan.
• On June 25, 2024, 10,134 ADSs were sold at a weighted average price of $3.6939, with prices ranging from $3.60 to $3.805.
• On June 26, 2024, 22,968 ADSs were sold at a weighted average price of $3.3932, with prices ranging from $3.28 to $3.51.
• Following these transactions, Hughes-Wilson beneficially owns 34,548 ADSs.

Sentiment

Score: 5

Explanation: The document describes routine transactions related to executive compensation and tax obligations. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Industry Context

Sales of shares to cover tax obligations are a routine part of equity compensation plans, particularly for executives at publicly traded companies. This activity is disclosed to ensure transparency and compliance with securities regulations.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but the explanation provided mitigates this concern.

Key Dates